Home » Topics » Science » New compound

New compound
RSS

Pfizer characterizes new antipsychotic agent

April 17, 1997

New cell adhesion inhibitor from Biogen

April 17, 1997

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

April 17, 1997

New fibrinogen antagonist from DuPont Merck

April 17, 1997

DuPont Merck presents new thrombin inhibitor

April 17, 1997

Potent and selective ETA antagonist from SKB

April 16, 1997

Biogen reveals new cell adhesion inhibitor

April 16, 1997

New bladder-selective M3 antagonist reported by Yamanouchi

April 16, 1997

Potential BPH therapy from Abbott

April 16, 1997

New COX-2 inhibitor from Searle

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...